NASDAQ: MCRBSeres Therapeutics Inc Earnings Dates, Reports, Calls
Seres Therapeutics earnings were -$46.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MCRB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$19.9M, up 29.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MCRB reported annual earnings of $5.7M, with 4,088.2% growth.
MCRB earnings history
Current Revenue
$1.1M
Current Earnings
-$46.9M
Current Profit Margin
-4,088.8%
MCRB Return on Equity
Current Company
-127.3%
Current Industry
-145.3%
Current Market
5.2%
MCRB's Return on Equity (-127.3%)... subscribe to Premium to read more.
High Return on Equity Performance
MCRB Return on Assets
Current Company
-34.5%
Current Industry
-9.7%
MCRB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when MCRB announces earnings.
MCRB Return on Capital Employed
Current Company
-47.72%
Current Industry
-5.8%
MCRB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
MCRB vs Biotech Stocks
Seres Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.